Orthopediatrics Corp Intrinsic Stock Value – ORTHOPEDIATRICS CORP Reports 14.4% Increase in Q3 Revenue for FY2023

November 21, 2023

☀️Earnings Overview

On November 6, 2023, ORTHOPEDIATRICS CORP ($NASDAQ:KIDS) reported their FY2023 Q3 earnings, with total revenue of USD 40.0 million, a 14.4% increase from the same quarter in 2022. Net income for the quarter was USD -4.6 million, compared to USD 18.5 million the previous year.

Analysis – Orthopediatrics Corp Intrinsic Stock Value

GoodWhale has conducted an analysis of the fundamentals of ORTHOPEDIATRICS CORP. Our proprietary Valuation Line has indicated that the intrinsic value of ORTHOPEDIATRICS CORP’s shares is around $59.0. Currently, the ORTHOPEDIATRICS CORP stock is trading at $27.4, which represents a 53.6% undervaluation. This pricing discrepancy provides a great opportunity for investors to get a good return on their investments. More…

  • Star Chart Analysis
  • Valuation Analysis
  • About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Orthopediatrics Corp. More…

    Total Revenues Net Income Net Margin
    142.11 -21.96 -17.3%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Orthopediatrics Corp. More…

    Operations Investing Financing
    -22.84 0.53 -2.12
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Orthopediatrics Corp. More…

    Total Assets Total Liabilities Book Value Per Share
    432.44 58.12 16.03
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Orthopediatrics Corp are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    26.0% -15.7%
    FCF Margin ROE ROA
    -24.9% -3.7% -3.2%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items

  • Peers

    The medical device industry is fiercely competitive, with OrthoPediatrics Corp competing against Acotec Scientific Holdings Ltd, ECGI Holdings Inc, and CVR Medical Corp. All four companies are striving to develop the best products and services to meet the needs of their patients. While all four companies offer different products and services, they all share a commitment to providing the highest quality care possible.

    – Acotec Scientific Holdings Ltd ($SEHK:06669)

    Acotec Scientific Holdings Ltd is a company that focuses on the research and development of medical technologies. They have a market capitalization of 2.53 billion as of 2022 and a return on equity of -3.65%. The company’s products are used in the treatment of various diseases and conditions, including cancer, cardiovascular disease, and neurological disorders.

    – ECGI Holdings Inc ($OTCPK:ECGI)

    ECGI Holdings Inc is a holding company that operates in the real estate industry. The company has a market capitalization of 1.7 million as of 2022 and a return on equity of 400.03%. ECGI Holdings Inc is engaged in the business of owning, developing, and managing real estate properties. The company’s portfolio of properties includes residential, commercial, and industrial properties.


    ORTHOPEDIATRICS CORP reported its Q3 financial results for FY2023, showing total revenue of USD 40.0 million, with a year-on-year growth of 14.4%.

    However, their net income for the same quarter declined significantly to USD -4.6 million compared to USD 18.5 million in the same period last year. Investors should be wary of this earnings report and assess the company’s financial position before making any decisions. It is also necessary to analyze their past performance in order to make an informed decision. Short-term investors may want to stay away from ORTHOPEDIATRICS CORP at this moment, while long-term investors should research the company further before investing.

    Recent Posts

    Leave a Comment